Publications
Max Planck Research Group Jachimowicz
Journal Article (5)
2022
Journal Article
Distinct genetically-determined origins of Myd88/Bcl2-driven aggressive lymphoma rationalize targeted therapeutic intervention strategies. Blood Cancer Discov (2022)
Journal Article
11 (20) (2022)
Genomic Amplification of UBQLN4 Is a Prognostic and Treatment Resistance Factor. Cells
Journal Article
24 (1), p. 41 (2022)
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer. Breast Cancer Res
Journal Article
Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination. Infection (2022)
Journal Article
Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination. Infection, pp. 1 - 6 (2022)